• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Tuesday, April 7, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Biology

Fetal T cells are first responders to infection in adults

Bioengineer by Bioengineer
June 20, 2018
in Biology
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

ITHACA, N.Y. – Cornell University researchers have discovered there is a division of labor among immune cells that fight invading pathogens in the body.

The study, published in the journal Cell, finds for the first time that fetal immune cells are present in adults and have specialized roles during infection. In fact, the first immune cells made in early life are fast-acting first responders to microbes in adulthood.

These immune cells – called CD8+ T cells – come in fetal and adult varieties, which originate in separate parts of the body and are hardwired with intrinsically different properties. The current paradigm is that, around the time of birth, the body switches from making and using fetal T cells to adult T cells to defend itself. But Cornell researchers used a unique study design to show that fetal T cells persist into adulthood and have different roles than adult cells in fighting infection.

"This discovery has led to the new idea that we might be able to predict how individuals will respond to infection based on how many fetal cells are present in the adult pool and isolate the fast-acting fetal-derived cells for certain therapeutic interventions, such as infections and cancer immunotherapy," said Brian Rudd, associate professor of immunology in the College of Veterinary Medicine and the paper's senior author. Norah Smith, a research associate in Rudd's lab, is the paper's first author.

In adults, newly formed T cells recognize a signature protein on a pathogen when they first encounter it. That signal then activates the T cells and equips them to fight and proliferate up to 15 times, producing up to 10 million cells in a week. Once the pathogen has been cleared, most of those adult T cells die, but up to 10 percent survive and are stored in a pool of memory cells, allowing for a rapid recall response if that same pathogen were to strike again.

Fetal-derived cells, on the other hand, are generalists and do not form into memory cells. They respond to inflammatory signals and activate faster than adult T cells, allowing them to provide a broad swath of protection against pathogens they don't specifically recognize, Rudd said.

"It's the way that the immune system hedges its bet: It has cells that can respond at different rates," Rudd said.

Future work will explore how genetic and environmental factors, such as diet and gut bacteria, may alter the developmental layers in the immune system.

###

The study was funded by the National Institutes of Health and the National Health and Medical Research Council in Australia.

Cornell University has television, ISDN and dedicated Skype/Google+ Hangout studios available for media interviews.

Media Contact

Jeff Tyson
[email protected]
607-793-5769
@cornell

http://pressoffice.cornell.edu

http://news.cornell.edu/stories/2018/06/fetal-t-cells-are-first-responders-infection-adults

Related Journal Article

http://dx.doi.org/10.1016/j.cell.2018.05.029

Share12Tweet8Share2ShareShareShare2

Related Posts

Peptidoglycan Patterns Guide Streptococcus pneumoniae Division

Peptidoglycan Patterns Guide Streptococcus pneumoniae Division

April 7, 2026
Protein Behind Cancer Cell Resistance to Treatment Uncovered

Protein Behind Cancer Cell Resistance to Treatment Uncovered

April 7, 2026

New Tool Developed to Predict CRRT Risk and Enhance Early AKI Management After Lung Transplantation

April 6, 2026

How Mitochondrial DNA Influences Your Health: What Science Reveals

April 6, 2026
Please login to join discussion

POPULAR NEWS

  • blank

    Revolutionary AI Model Enhances Precision in Detecting Food Contamination

    97 shares
    Share 39 Tweet 24
  • Promising Outcomes from First Clinical Trials of Gene Regulation in Epilepsy

    51 shares
    Share 20 Tweet 13
  • Imagine a Social Media Feed That Challenges Your Views Instead of Reinforcing Them

    1009 shares
    Share 399 Tweet 249
  • Popular Anti-Aging Compound Linked to Damage in Corpus Callosum, Study Finds

    44 shares
    Share 18 Tweet 11

About

BIOENGINEER.ORG

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Tsu-Jae Liu’s Editorial Explores the Impact of AI on Engineering Innovation

PHIP Inhibits NuRD to Boost SWI/SNF Cancer Growth

Targeted Therapy Boosts Immune Attack in Ovarian Cancer

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 78 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.